CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

UBS Adjusts Price Target on AbbVie to $260 From $230, Maintains Neutral Rating

Positive
AI Analysis

Summary

UBS raised its price target on AbbVie to $260 from $230 while maintaining a Neutral rating on the stock.

Importance:2/10
Sentiment:
0.30
price_targetanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 13, 2026 1:46 PM

Read Original